CoChat

Virulence factors in biofilm formation and therapeutic strategies for Staphylococcus aureus: A review

Wang, Dali, Wang, Li, Liu, Quan, Zhao, Yicheng · 2025 · Animals and Zoonoses
Cited by 57

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Staphylococcus aureus ( S. aureus ) is a significant human pathogen known for its ability to form biofilms, which increase its resistance to antibiotics and immune defenses. This review delves into the mechanisms of biofilm formation in S. aureus , emphasizing the critical roles of various virulence factors. During the initial attachment phase, surface proteins such as protein A, fibronectin-binding proteins (FnBPs), and clumping factors (ClfA and ClfB) are anchored by sortase A (SrtA), facilitating adherence to host tissues and surfaces. Biofilm maturation is driven by polysaccharide intercellular adhesin (PIA), while the extracellular polymeric substance (EPS) matrix—comprising polysaccharides, extracellular DNA, proteins, and lipids—reinforces biofilm stability and defense mechanisms. Regulatory systems such as MgrA, ClpP, and the SaeR/SaeS two-component system dynamically modulate the expression of virulence and biofilm-associated genes, enabling bacterial adaptation to environmental stressors. Additionally, toxins such as alpha-hemolysin (Hla) and enzymes such as coagulase (Coa) and von Willebrand factor-binding protein (vWbp) play pivotal roles in immune evasion and biofilm protection. This review also explores emerging therapeutic strategies that target these virulence factors, highlighting their potential in treating persistent S. aureus infections. Understanding the intricate interplay between virulence factors and biofilm formation provides valuable insights for developing of more effective therapeutic interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.azn.2024.11.003

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 253

  1. Gherardi, 2023, Staphylococcus aureus infection: pathogenesis and antimicrobial resistance, MDPI, 8182
  2. T.L.Holland, Ceftobiprole for treatment of complicated Staphylococcus aureus bacteremia. 2023. 389(15): p. 1390–1401. https://doi.org/10.1056/NEJMoa2300220 · DOI · Paper page
  3. B.P.Howden, Staphylococcus aureus host interactions and adaptation. 2023. 21(6): p. 380–95. https://doi.org/10.1038/s41579-023-00852-y · DOI · Paper page
  4. M.S.Linz, Clinical impact of Staphylococcus aureus skin and soft tissue infections. 2023. 12(3): p. 557. https://doi.org/10.3390/antibiotics12030557 · DOI · Paper page
  5. Kebriaei, R., et al., Optimization of phage-antibiotic combinations against Staphylococcus aureus biofilms. 2023. 11(3): p. e04918–22. https://doi.org/10.1128/spectrum.04918-22 · DOI · Paper page
  6. M.Khaleghian, In silico design and mechanistic study of niosome-encapsulated curcumin against multidrug-resistant Staphylococcus aureus biofilms. 2023. 14: p. 1277533. https://doi.org/10.3389/fmicb.2023.1277533 · doi:10.3389/fmicb.2023.1277533
  7. M.Malani, Carboxylated nanofibrillated cellulose empowers moxifloxacin to overcome Staphylococcus aureus biofilm in bacterial keratitis. 2024. 324: p. 121558. https://doi.org/10.1016/j.carbpol.2023.121558 · DOI
  8. Mao, Y., et al., Baicalein inhibits the Staphylococcus aureus biofilm and the LuxS/AI-2 system in vitro. 2023: p. 2861–82. https://doi.org/10.2147/IDR.S406243 · DOI
  9. N.N.Tran, Current therapies and challenges for the treatment of Staphylococcus aureus biofilm-related infections. 2023. 43(8): p. 816–32. https://doi.org/10.1002/phar.2806 · DOI
  10. Wu, X., et al., Staphylococcus aureus biofilm: formulation, regulatory, and emerging natural products-derived therapeutics. 2024: p. 100175. https://doi.org/10.1016/j.bioflm.2023.100175 · DOI
  11. Yap, C.H., et al., Synthesis and Staphylococcus aureus biofilm inhibitory activity of indolenine-substituted pyrazole and pyrimido [1, 2-b] indazole derivatives. 2023. 95: p. 117485. https://doi.org/10.1016/j.bmc.2023.117485 · DOI
  12. Yu, Y.-L., et al., Elimination of methicillin-resistant Staphylococcus aureus biofilms on titanium implants via photothermally-triggered nitric oxide and immunotherapy for enhanced osseointegration. 2023. 10(1): p. 21. https://doi.org/10.1186/s40779-023-00454-y · DOI
  13. Tabassum, N., et al., Treatment of Staphylococcus aureus and Candida albicans polymicrobial biofilms by phloroglucinol-gold nanoparticles. 2023. 185: p. 106416. https://doi.org/10.1016/j.micpath.2023.106416 · DOI
  14. Fernández-Grajera, M., et al., Dynamic adhesive behavior and biofilm formation of staphylococcus aureus on polylactic acid surfaces in diabetic environments. 2024. 17(13): p. 3349. https://doi.org/10.3390/ma17133349 · DOI
  15. Hernández-Cuellar, E., et al., Differences in biofilm formation by methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. 2023. 11(4): p. 160. https://doi.org/10.3390/diseases11040160 · DOI
  16. Martínez, A., et al., Effect of essential oil from Lippia origanoides on the transcriptional expression of genes related to quorum sensing, biofilm formation, and virulence of Escherichia coli and Staphylococcus aureus. 2023. 12(5): p. 845. https://doi.org/10.3390/antibiotics12050845 · DOI
  17. Long, D.R., et al., In vitro selection identifies Staphylococcus aureus genes influencing biofilm formation. 2023. 91(3): p. e00538–22. https://doi.org/10.1128/iai.00538-22 · doi:10.1128/iai.00538-22
  18. Vargová, M., et al., Biofilm-producing ability of Staphylococcus aureus obtained from surfaces and milk of mastitic cows. 2023. 10(6): p. 386. https://doi.org/10.3390/vetsci10060386 · DOI
  19. Ciszek-Lenda, M., et al., Biofilm-forming strains of P. aeruginosa and S. aureus isolated from cystic fibrosis patients differently affect inflammatory phenotype of macrophages. 2023. 72(6): p. 1275–89. https://doi.org/10.1007/s00011-023-01743-x · DOI
  20. Xiao, Y., et al., Novel small-molecule compound YH7 inhibits the biofilm formation of Staphylococcus aureus in a sarX-dependent manner. 2024. 9(1): p. e00564–23. https://doi.org/10.1128/msphere.00564-23 · DOI
  21. Ramachandran, G., et al., Chitosan/silver nanocomposites enhanced the biofilm eradication in biofilm forming Gram positive S. aureus. 2023. 35(4): p. 102597. https://doi.org/10.1016/j.jksus.2023.102597 · doi:10.1016/j.jksus.2023.102597
  22. Bai, X., et al., Anti-biofilm activity of biochanin A against Staphylococcus aureus. 2023. 107(2): p. 867–79. https://doi.org/10.1007/s00253-022-12350-x · doi:10.1007/s00253-022-12350-x
  23. Luo, Z.-x., et al., Ciprofloxacin enhances the biofilm formation of Staphylococcus aureus via an agrC-dependent mechanism. 2023. 14: p. 1328947. https://doi.org/10.3389/fmicb.2023.1328947 · DOI
  24. Li, M., et al., Interactions between macrophages and biofilm during Staphylococcus aureus-associated implant infection: difficulties and solutions. 2023. 15(1): p. 499–515. https://doi.org/10.1159/000530385 · DOI
  25. Omar, W.H.W., et al., Effect of natural antibacterial clays against single biofilm formation by Staphylococcus aureus and Salmonella Typhimurium bacteria on a stainless-steel surface. 2023. 394: p. 110184. https://doi.org/10.1016/j.ijfoodmicro.2023.110184 · doi:10.1016/j.ijfoodmicro.2023.110184
  26. Dai, J., et al., Occurrence, antibiotic susceptibility, biofilm formation and molecular characterization of Staphylococcus aureus isolated from raw shrimp in China. 2023. 12(14): p. 2651. https://doi.org/10.3390/foods12142651 · DOI
  27. François, P., J. Schrenzel, F. Götz, Biology and regulation of staphylococcal biofilm. 2023. 24(6): p. 5218. https://doi.org/10.3390/ijms24065218 · DOI
  28. Shaghayegh, G., et al., Staphylococcus aureus biofilm properties and chronic rhinosinusitis severity scores correlate positively with total CD4+ T-cell frequencies and inversely with its Th1, Th17 and regulatory cell frequencies. 2023. 170(1): p. 120–33. https://doi.org/10.1111/imm.13655 · DOI
  29. Yadav, M.K., A. Baldia, S.K. Tiwari, Plantaricin LD1 inhibits the growth and biofilm formation of Staphylococcus aureus in milk. 2024. 9(1): p. 1–7. https://doi.org/10.14218/jerp.2023.00011 · DOI
  30. Tuon, F.F., et al., Antimicrobial treatment of Staphylococcus aureus biofilms. 2023. 12(1): p. 87. https://doi.org/10.3390/antibiotics12010087 · DOI · Paper page
  31. Liang, J., et al., Biofilm formation of two genetically diverse Staphylococcus aureus isolates under beta-lactam antibiotics. 2023. 14: p. 1139753. https://doi.org/10.3389/fmicb.2023.1139753 · DOI
  32. Shaghayegh, G., et al., Chronic rhinosinusitis patients display an aberrant immune cell localization with enhanced S aureus biofilm metabolic activity and biomass. 2023. 151(3): p. 723–36. e16. https://doi.org/10.1016/j.jaci.2022.08.031 · DOI
  33. Sharan, M., et al., Characterization of chicken eggs associated Escherichia coli and Staphylococcus aureus for biofilm production and antimicrobial resistance traits. 2023. 34(8): p. 3533–44. https://doi.org/10.1080/10495398.2023.2171423 · DOI
  34. Jeong, G.-J., et al., Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid. 2023: p. 106941. https://doi.org/10.1016/j.ijantimicag.2023.106941 · DOI
  35. Mamdoh, H., et al., Clinical and bacteriological analyses of biofilm-forming Staphylococci isolated from diabetic foot ulcers. 2023: p. 1737–50. https://doi.org/10.2147/IDR.S393724 · DOI
  36. Hamad PA. Phenotypic and molecular detection of biofilm formation in methicillin-resistant Staphylococcus aureus isolated from different clinical sources in Erbil city. 2023. 1: p. 15. https://doi.org/10.4084/MJHID.2023.016 · doi:10.4084/mjhid.2023.016
  37. Katsipis, G., A.A. Pantazaki, Serrapeptase impairs biofilm, wall, and phospho-homeostasis of resistant and susceptible Staphylococcus aureus. 2023. 107(4): p. 1373–89. https://doi.org/10.1007/s00253-022-12356-5 · DOI
  38. Li, H., et al., Cuminaldehyde inhibits biofilm formation by affecting the primary adhesion of Staphylococcus aureus. 2023. 156: p. 13–20. https://doi.org/10.1016/j.sajb.2023.02.031 · doi:10.1016/j.sajb.2023.02.031
  39. Zhu, Z., et al., Molecular characteristics and pathogenicity of staphylococcus aureus exotoxins. 2023. 25(1): p. 395. https://doi.org/10.3390/ijms25010395 · DOI
  40. Sun, J., et al., Antimicrobial nanostructured assemblies with extremely low toxicity and potent activity to eradicate Staphylococcus aureus biofilms. 2023. 19(3): p. 2204039. https://doi.org/10.1002/smll.202204039 · DOI
  41. Parvin, F., et al., Staphylococcus aureus cell wall phenotypic changes associated with biofilm maturation and water availability: a key contributing factor for chlorine resistance. 2023. 24(5): p. 4983. https://doi.org/10.3390/ijms24054983 · DOI
  42. Peng, Q., et al., Carvacrol inhibits bacterial polysaccharide intracellular adhesin synthesis and biofilm formation of mucoid Staphylococcus aureus: an in vitro and in vivo study. 2023. 13(41): p. 28743–52. https://doi.org/10.1039/d3ra02711b · DOI
  43. Tello-Díaz, C., et al., Methicillin-susceptible Staphylococcus aureus biofilm formation on vascular grafts: an in vitro study. 2023. 11(2): p. e03931–22. https://doi.org/10.1128/spectrum.03931-22 · doi:10.1128/spectrum.03931-22
  44. Ersanli, C., et al., The assessment of antimicrobial and anti-biofilm activity of essential oils against Staphylococcus aureus strains. 2023. 12(2): p. 384. https://doi.org/10.3390/antibiotics12020384 · DOI
  45. Shen, L., et al., Small-molecule compound CY-158-11 inhibits Staphylococcus aureus biofilm formation. 2023. 11(3): p. e00045–23. https://doi.org/10.1128/spectrum.00045-23 · DOI
  46. Rather, I.A., et al., Limosilactobacillus fermentum KAU0021 abrogates mono-and polymicrobial biofilms formed by Candida albicans and Staphylococcus aureus. 2023. 15(4): p. 1079. https://doi.org/10.3390/pharmaceutics15041079 · DOI
  47. Xu, Z., et al., Cell-wall-anchored proteins affect invasive host colonization and biofilm formation in Staphylococcus aureus. 2024: p. 127782. https://doi.org/10.1016/j.micres.2024.127782 · DOI
  48. Bhattacharya M, Horswill AR. The role of human extracellular matrix proteins in defining Staphylococcus aureus biofilm infections. 2024. 48(1): pfuae002. https://doi.org/10.1093/femsre/fuae002 · DOI · Paper page
  49. Motta, C., et al., von Willebrand factor-binding protein (vWbp)-activated factor XIII and transglutaminase 2 (TG2) promote cross-linking between FnBPA from Staphylococcus aureus and fibrinogen. 2023. 13(1): p. 11683. https://doi.org/10.1038/s41598-023-38972-3 · doi:10.1038/s41598-023-38972-3
  50. Risser, F., et al., Adhesive virulence factors of Staphylococcus aureus resist digestion by coagulation proteases thrombin and plasmin. 2022. 2(6): p. 586–99. https://doi.org/10.1021/acsbiomedchemau.2c00042 · DOI
  51. Torres, G., et al., Evaluation of three Staphylococcus aureus proteins involved in the adhesion process as antigens for the detection of bovine intramammary infections. 2022. 71(12): p. 001613. https://doi.org/10.1099/jmm.0.001613 · DOI
  52. Speziale P, Pietrocola G. Monoclonal antibodies targeting surface-exposed and secreted proteins from staphylococci. 2021. 9(5): p459. https://doi.org/10.3390/vaccines9050459 · DOI · Paper page
  53. Berry, K.A., et al., Staphylococcus aureus adhesion to the host. 2022. 1515(1): p. 75–96. https://doi.org/10.1111/nyas.14807 · DOI
  54. Schnurr, E., et al., Staphylococcus aureus interferes with streptococci spatial distribution and with protein expression of species within a polymicrobial oral biofilm. 2021. 10(2): p. 116. https://doi.org/10.3390/antibiotics10020116 · DOI
  55. Mirzaei, B., et al., Staphylococcal vaccine antigens related to biofilm formation. 2021. 17(1): p. 293–303. https://doi.org/10.1080/21645515.2020.1767449 · DOI
  56. Wu, S., et al., The role of Staphylococcus aureus YycFG in gene regulation, biofilm organization and drug resistance. 2021. 10(12): p. 1555. https://doi.org/10.3390/antibiotics10121555 · DOI
  57. Ortega-Peña, S., et al., Overview of Staphylococcus epidermidis cell wall-anchored proteins: potential targets to inhibit biofilm formation. 2020. 47: p. 771–84. https://doi.org/10.1007/s11033-019-05139-1 · DOI
  58. Chan, Y.L., et al., Unveilling genetic profiles and correlations of biofilm-associated genes, quorum sensing, and antibiotic resistance in Staphylococcus aureus isolated from a Malaysian Teaching Hospital. 2024. 29(1): p. 246. https://doi.org/10.1186/s40001-024-01831-6 · doi:10.1186/s40001-024-01831-6
  59. Király, J., et al., Resistant S. aureus Isolates capable of producing biofilm from the milk of dairy cows with subclinical mastitis in Slovakia. 2024. 14(4): p. 571. https://doi.org/10.3390/agriculture14040571 · DOI
  60. Kaźmierczak, N., B. Grygorcewicz, L. Piechowicz, Biofilm formation and prevalence of biofilm-related genes among clinical strains of multidrug-resistant Staphylococcus aureus. 2021. 27(7): p. 956–64. https://doi.org/10.1089/mdr.2020.0399 · doi:10.1089/mdr.2020.0399
  61. Parastan, R., et al., Staphylococcus aureus biofilms: structures, antibiotic resistance, inhibition, and vaccines. 2020. 20: p. 100739. https://doi.org/10.1016/j.genrep.2020.100739 · DOI · Paper page
  62. Hait, J.M., et al., Evaluation of virulence determinants using whole-genome sequencing and phenotypic biofilm analysis of outbreak-linked Staphylococcus aureus isolates. 2021. 12: p. 687625. https://doi.org/10.3389/fmicb.2021.687625 · doi:10.3389/fmicb.2021.687625
  63. Tomlinson, B.R., M.E. Malof, L.N. Shaw, A global transcriptomic analysis of Staphylococcus aureus biofilm formation across diverse clonal lineages. 2021. 7(7): p. 000598. https://doi.org/10.1099/mgen.0.000598 · DOI
  64. Nguyen, H.T., et al., The staphylococcal exopolysaccharide PIA–biosynthesis and role in biofilm formation, colonization, and infection. 2020. 18: p. 3324–34. https://doi.org/10.1016/j.csbj.2020.10.027 · DOI · Paper page
  65. Hao, Z., et al., Deletion of SarX decreases biofilm formation of Staphylococcus aureus in a polysaccharide intercellular adhesin (PIA)-dependent manner by downregulating spa. 2021: p. 2241–50. https://doi.org/10.2147/IDR.S305650 · DOI
  66. e Silva, A.Ad.L., et al., Diclofenac may induce PIA-independent biofilm formation in Staphylococcus aureus strains. 2021. 2021. https://doi.org/10.1155/2021/8823775 · DOI
  67. Azzam, A., R.M. Shawky, T.S. El-Mahdy, Sub-inhibitory concentrations of ceftriaxone induce morphological alterations and PIA-independent biofilm formation in Staphylococcus aureus. 2024. 55(1): p. 297–308. https://doi.org/10.1007/s42770-023-01177-x · DOI
  68. Mirzaei, B., et al., PIA and rSesC mixture arisen antibodies could inhibit the biofilm-formation in Staphylococcus aureus. 2021. 10(1): p. 1. https://doi.org/10.52547/rbmb.10.1.1 · DOI
  69. Idrees, M., et al., Staphylococcus aureus biofilm: morphology, genetics, pathogenesis and treatment strategies. 2021. 18(14): p. 7602. https://doi.org/10.3390/ijerph18147602 · DOI · Paper page
  70. Nasser, A., et al., Staphylococcus aureus: biofilm formation and strategies against it. 2022. 23(5): p. 664–78. https://doi.org/10.2174/1389201022666210708171123 · DOI
  71. Zhang, C., et al., Berberine at sub-inhibitory concentration inhibits biofilm dispersal in Staphylococcus aureus. 2022. 168(9): p. 001243. https://doi.org/10.1099/mic.0.001243 · DOI
  72. Silva-Santana, G., et al., Staphylococcus aureus biofilms: an opportunistic pathogen with multidrug resistance. 2021. 32(1): p. 12–21. https://doi.org/10.1097/MRM.0000000000000223 · DOI
  73. Piras, C., et al., S. aureus biofilm protein expression linked to antimicrobial resistance: a proteomic study. 2021. 11(4): p. 966. https://doi.org/10.3390/ani11040966 · DOI
  74. Qi, M., et al., Staphylococcus aureus biofilm inhibition by high voltage prick electrostatic field (HVPEF) and the mechanism investigation. 2022. 362: p. 109499. https://doi.org/10.1016/j.ijfoodmicro.2021.109499 · DOI
  75. e Silva, A.Ad.L., et al., Research article diclofenac may induce PIA-independent biofilm formation in Staphylococcus aureus Strains. 2021. https://doi.org/10.1155/2021/8823775 · DOI
  76. Lamret, F., et al., Staphylococcus aureus strain-dependent biofilm formation in bone-like environment. 2021. 12: p. 714994. https://doi.org/10.3389/fmicb.2021.714994 · DOI
  77. Cáceres, M.E., et al., Growth conditions affect biofilms of Staphylococcus aureus producing mastitis: contribution of MALDI-TOF-MS to strain characterization. 2021. 2: p. 100073. https://doi.org/10.1016/j.crmicr.2021.100073 · doi:10.1016/j.crmicr.2021.100073
  78. Qiao, J., et al., Research on the biofilm formation of Staphylococcus aureus after cold stress. 2021. 9(7): p. 1534.https://doi.org/10.3390/microorganisms9071534 · doi:10.3390/microorganisms9071534
  79. Rahman, M.A., et al., Proteome of Staphylococcus aureus biofilm changes significantly with aging. 2022. 23(12): p. 6415. https://doi.org/10.3390/ijms23126415 · DOI
  80. Schwartbeck, B., et al., Various mutations in icaR, the repressor of the icaADBC locus, occur in mucoid Staphylococcus aureus isolates recovered from the airways of people with cystic fibrosis. 2024. 26(4): p. 105306. https://doi.org/10.1016/j.micinf.2024.105306 · DOI
  81. Mu, Y., et al., Streptomyces-derived actinomycin D inhibits biofilm formation via downregulating ica locus and decreasing production of PIA in Staphylococcus epidermidis. 2020. 128(4): p. 1201–7. https://doi.org/10.1111/jam.14543 · DOI
  82. Spiegel, C., S.J.M. Steixner, D.C. Coraça-Huber, Antibiofilm activity of omega-3 fatty acids and its influence on the expression of biofilm formation genes on Staphylococcus aureus. 2022. 11(7): p. 932. https://doi.org/10.3390/antibiotics11070932 · DOI
  83. Li, H., et al., Inhibition mechanism of cyclo (L-Phe-L-Pro) on early stage Staphylococcus aureus biofilm and its application on food contact surface. 2022. 49: p. 101968. https://doi.org/10.1016/j.fbio.2022.101968 · DOI
  84. Sang, H., et al., Gallic acid exerts antibiofilm activity by inhibiting methicillin-resistant Staphylococcus aureus adhesion. 2024. 14(1): p. 17220. https://doi.org/10.1038/s41598-024-68279-w · DOI
  85. Vila, T., et al., Therapeutic implications of C. albicans-S. aureus mixed biofilm in a murine subcutaneous catheter model of polymicrobial infection. 2021. 12(1): p. 835–51. https://doi.org/10.1080/21505594.2021.1894834 · DOI
  86. Bulock, L.L., et al., Interplay of CodY and CcpA in regulating central metabolism and biofilm formation in Staphylococcus aureus. 2022. 204(7): p. e00617–21. https://doi.org/10.1128/jb.00617-21 · DOI
  87. Avila-Novoa, M.G., et al., Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) strains isolated from dairy products: relationship of ica-dependent/independent and components of biofilms produced in vitro. 2021. 119: p. 105066. https://doi.org/10.1016/j.idairyj.2021.105066 · DOI
  88. Guo, N., et al., Target-based screening for natural products against Staphylococcus aureus biofilms. 2023. 63(14): p. 2216–2230. https://doi.org/10.1080/10408398.2021.1972280 · doi:10.1080/10408398.2021.1972280
  89. Pietrocola, G., et al., Colonization and infection of indwelling medical devices by Staphylococcus aureus with an emphasis on orthopedic implants. 2022. 23(11): p. 5958. https://doi.org/10.3390/ijms23115958 · DOI
  90. Kot, B., et al., Effect of manuka honey on biofilm-associated genes expression during methicillin-resistant Staphylococcus aureus biofilm formation. 2020. 10(1): p. 13552. https://doi.org/10.1038/s41598-020-70666-y · DOI · Paper page
  91. Marincola, G., et al., Plasmid-chromosome crosstalk in Staphylococcus aureus: a horizontally acquired transcription regulator controls polysaccharide intercellular adhesin-mediated biofilm formation. 2021. 11: p. 660702. https://doi.org/10.3389/fcimb.2021.660702 · DOI
  92. Ball, A.L., et al., Characterization of Staphylococcus aureus biofilms via crystal violet binding and biochemical composition assays of isolates from hospitals, raw meat, and biofilm-associated gene mutants. 2022. 167: p. 105554. https://doi.org/10.1016/j.micpath.2022.105554 · DOI
  93. Liu, Y., J. Zhang, Y. Ji, Environmental factors modulate biofilm formation by Staphylococcus aureus. 2020. 103(1): p. 0036850419898659. https://doi.org/10.1177/0036850419898659 · DOI
  94. Yuan, Z., et al., Thymol inhibits biofilm formation, eliminates pre-existing biofilms, and enhances clearance of methicillin-resistant Staphylococcus aureus (MRSA) in a mouse peritoneal implant infection model. 2020. 8(1): p. 99. https://doi.org/10.3390/microorganisms8010099 · DOI · Paper page
  95. Bowden, L.C., et al., Beyond the double helix: the multifaceted landscape of extracellular DNA in Staphylococcus aureus biofilms. 2024. 14: p. 1400648. https://doi.org/10.3389/fcimb.2024.1400648 · DOI
  96. Ravaioli, S., et al., Various biofilm matrices of the emerging pathogen Staphylococcus lugdunensis: exopolysaccharides, proteins, eDNA and their correlation with biofilm mass. 2020. 36(1): p. 86–100. https://doi.org/10.1080/08927014.2020.1716217 · DOI
  97. Sivori, F., et al., Role of extracellular DNA in dalbavancin activity against methicillin-resistant Staphylococcus aureus (MRSA) biofilms in patients with skin and soft tissue infections. 2022. 10(2): p. e00351–22. https://doi.org/10.1128/spectrum.00351-22 · DOI
  98. Tian, L.-L., et al., Low concentrations of tetrabromobisphenol A promote the biofilm formation of methicillin-resistant Staphylococcus aureus. 2024. 283: p. 116853. https://doi.org/10.1016/j.ecoenv.2024.116853 · DOI
  99. Kaplan JB, Horswill AR. Micrococcal nuclease regulates biofilm formation and dispersal in methicillin-resistant Staphylococcus aureus USA300. 2024. 9(5): p. e00126–24. https://doi.org/10.1128/msphere.00126-24 · DOI
  100. Mlynek, K.D., et al., Genetic and biochemical analysis of CodY-mediated cell aggregation in Staphylococcus aureus reveals an interaction between extracellular DNA and polysaccharide in the extracellular matrix. 2020. 202(8): p. 10.1128/jb. 00593-19. https://doi.org/10.1128/JB.00593-19 · DOI · Paper page
  101. Panlilio, H., C.V. Rice, The role of extracellular DNA in the formation, architecture, stability, and treatment of bacterial biofilms. 2021. 118(6): p. 2129–41. https://doi.org/10.1002/bit.27760 · DOI · Paper page
  102. Ong, Z.X., et al., Investigation of Staphylococcus aureus biofilm-associated toxin as a potential squamous cell carcinoma therapeutic. 2024. 12(2): p. 293. https://doi.org/10.3390/microorganisms12020293 · DOI
  103. Fesharaki, M.J., et al., Virulence factors of Staphylococcus aureus hemolysin HLA and HLB isolated from catheters of dialysis patients referred to Nikan Hospital in Tehran during the spring and summer of 2021. 2022. 16(6): p. 348. https://doi.org/10.52547/ijkd.7146 · doi:10.52547/ijkd.7146
  104. Motallebi, M., et al., Molecular analysis and the toxin, MSCRAMM, and biofilm genes of methicillin-resistant Staphylococcus aureus strains isolated from pemphigus wounds: a study based on SCCmec and dru typing. 2021. 87: p. 104644. https://doi.org/10.1016/j.meegid.2020.104644 · doi:10.1016/j.meegid.2020.104644
  105. Wang, T., et al., A natural dietary flavone myricetin as an α-hemolysin inhibitor for controlling Staphylococcus aureus infection. 2020. 10: p. 330. https://doi.org/10.3389/fcimb.2020.00330 · DOI
  106. Guo, H., et al., Biofilm and small colony variants—an update on Staphylococcus aureus strategies toward drug resistance. 2022. 23(3): p. 1241. https://doi.org/10.3390/ijms23031241 · DOI · Paper page
  107. Heim, C.E., et al., Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection. 2020. 5(10): p. 1271–84. https://doi.org/10.1038/s41564-020-0756-3 · DOI · Paper page
  108. De Gregorio, E., et al., N-nonyloxypentyl-l-deoxynojirimycin inhibits growth, biofilm formation and virulence factors expression of Staphylococcus aureus. 2020. 9(6): p. 362. https://doi.org/10.3390/antibiotics9060362 · DOI
  109. Zheng, J., et al., Diclazuril inhibits biofilm formation and hemolysis of Staphylococcus aureus. 2021. 7(6): p. 1690–701. https://doi.org/10.1021/acsinfecdis.1c00030 · DOI
  110. Liu, Y., et al., Lapatinib acts against biofilm formation and the hemolytic activity of Staphylococcus aureus. 2022. 7(10): p. 9004–14. https://doi.org/10.1021/acsomega.2c00174 · DOI
  111. Hussain, M., C. Kohler, K. Becker, Role of SrtA in pathogenicity of Staphylococcus lugdunensis. 2020. 8(12): p. 1975. https://doi.org/10.3390/microorganisms8121975 · DOI
  112. Thappeta, K.R.V., et al., In-silico identified new natural sortase a inhibitors disrupt S. aureus biofilm formation. 2020. 21(22): p. 8601. https://doi.org/10.3390/ijms21228601 · DOI
  113. Yang, T., et al., Tideglusib and its analogues as inhibitors of Staphylococcus aureus SrtA. 2020. 63(15): p. 8442–57. https://doi.org/10.1021/acs.jmedchem.0c00803 · DOI
  114. Song, W., et al., Hibifolin, a natural sortase a inhibitor, attenuates the pathogenicity of Staphylococcus aureus and enhances the antibacterial activity of cefotaxime. 2022. 10(4): p. e00950–22. https://doi.org/10.1128/spectrum.00950-22 · DOI
  115. Yue, C., et al., Structure-guided design, synthesis, and antivirulence assessment of covalent Staphylococcus aureus sortase A inhibitors. 2024. 67(2): p. 1127–46. https://doi.org/10.1021/acs.jmedchem.3c01615 · DOI
  116. Wang, X., et al., The protection effect of rhodionin against methicillin-resistant Staphylococcus aureus-induced pneumonia through sortase A inhibition. 2023. 39(1): p. 18. https://doi.org/10.1007/s11274-022-03457-4 · DOI
  117. Wang, L., et al., Eriodictyol as a potential candidate inhibitor of sortase A protects mice from methicillin-resistant Staphylococcus aureus-induced pneumonia. 2021. 12: p. 635710. https://doi.org/10.3389/fmicb.2021.635710 · DOI
  118. Tian, L., et al., Exploring the modulatory impact of isosakuranetin on Staphylococcus aureus: Inhibition of sortase A activity and α-haemolysin expression. 2023. 14(1): p. 2260675. https://doi.org/10.1080/21505594.2023.2260675 · DOI
  119. Guan, X.-N., et al., Covalent sortase A inhibitor ML346 prevents Staphylococcus aureus infection of Galleria mellonella. 2022. 13(2): p. 138–49. https://doi.org/10.1039/d1md00316j · DOI
  120. Volynets, G.P., et al., Identification of novel small-molecular inhibitors of Staphylococcus aureus sortase A using hybrid virtual screening. 2022. 75(6): p. 321–32. https://doi.org/10.1038/s41429-022-00524-8 · DOI
  121. Nairn, B.L., et al., Uncovering roles of Streptococcus gordonii SrtA-processed proteins in the biofilm lifestyle. 2020. 203(2): p. 10.1128/jb. 00544-20. https://doi.org/10.1128/JB.00544-20 · DOI
  122. Kuai, 2024, Role of SarA in Staphylococcus aureus: a virulence target for therapeutic strategies, Prog Microbes Mol Biol, 7, 10.36877/pmmb.a0000444 · doi:10.36877/pmmb.a0000444
  123. Patel, 2023, A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis, Front Microbiol, 14, 1204428, 10.3389/fmicb.2023.1204428 · DOI
  124. Zhang, 2017, Chalcone attenuates Staphylococcus aureus virulence by targeting sortase A and alpha-hemolysin, Front Microbiol, 8, 1715, 10.3389/fmicb.2017.01715 · DOI · Paper page
  125. Wang, 2018, Oligopeptide targeting sortase a as potential anti-infective therapy for Staphylococcus aureus, Front Microbiol, 9, 245, 10.3389/fmicb.2018.00245 · DOI
  126. Crosby, H.A., et al., The Staphylococcus aureus ArlRS two-component system regulates virulence factor expression through MgrA. 2020. 113(1): p. 103–22. https://doi.org/10.1111/mmi.14404 · DOI · Paper page
  127. Guo, X., et al., Thwarting resistance: MgrA inhibition with methylophiopogonanone a unveils a new battlefront against S. aureus. 2024. 10(1): p. 15. https://doi.org/10.1038/s41522-024-00485-w · DOI
  128. Lee, J., et al., Functional mgrA influences genetic changes within a Staphylococcus aureus cell population over time. 2022. 204(10): p. e00138–22. https://doi.org/10.1128/jb.00138-22 · DOI
  129. Zheng, J., et al., Loratadine interacts with MgrA and inhibits Staphylococcus aureus virulence and biofilm formation. https://doi.org/10.1128/jb.00138-22 · DOI
  130. Chen, L., et al., The role of graRS in regulating virulence and antimicrobial resistance in methicillin-resistant Staphylococcus aureus. 2021. 12: p. 727104. https://doi.org/10.3389/fmicb.2021.727104 · DOI
  131. Kwiecinski, J.M., et al., Therapeutic inhibition of Staphylococcus aureus ArlRS two-component regulatory system blocks virulence. 2022. 66(7): p. e00187–22. https://doi.org/10.1128/aac.00187-22 · DOI
  132. Patel H, Rawat S. A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis. 2023: p. 1204428. https://doi.org/10.3389/fmicb.2023.1204428 · DOI
  133. Crosby, H.A., et al., Host-derived protease promotes aggregation of Staphylococcus aureus by cleaving the surface protein SasG. 2024. 15(4): p. e03483–23. https://doi.org/10.1128/mbio.03483-23 · DOI
  134. Aggarwal S, Singh DV. Efflux pumps and biofilm formation by both methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains. 2020. 58(08): p527–38. https://doi.org/10.56042/ijeb.v58i08.39406 · doi:10.56042/ijeb.v58i08.39406
  135. Lei, M.G., et al., Characterization of Ssc, an N-acetylgalactosamine-containing Staphylococcus aureus surface polysaccharide. 2024. 206(5): p. e00048–24. https://doi.org/10.1128/jb.00048-24 · doi:10.1128/jb.00048-24
  136. Costa, Md.O.Ce, et al., The gene regulatory network of Staphylococcus aureus ST239-SCC mec III strain Bmb9393 and assessment of genes associated with the biofilm in diverse backgrounds. 2023. 13: p. 1049819. https://doi.org/10.3389/fmicb.2022.1049819 · DOI
  137. Kim, S.-Y., M. Kim, T.-J.. Kim, Regulation of σB-dependent biofilm formation in Staphylococcus aureus through strain-specific signaling induced by diosgenin. 2023. 11(10): p. 2376. https://doi.org/10.3390/microorganisms11102376 · DOI
  138. Yu, Y., et al., Inhibition of efflux pump encoding genes and biofilm formation by sub-lethal photodynamic therapy in methicillin susceptible and resistant Staphylococcus aureus. 2022. 39: p. 102900. https://doi.org/10.1016/j.pdpdt.2022.102900 · doi:10.1016/j.pdpdt.2022.102900
  139. Elgrail, M.M., et al., Convergent evolution of antibiotic tolerance in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. 2022. 90(4): p. e00001–22. https://doi.org/10.1128/iai.00001-22 · DOI
  140. Yu, X., et al., Increased expression of efflux pump NorA drives the rapid evolutionary trajectory from tolerance to resistance against ciprofloxacin in Staphylococcus aureus. 2022. 66(12): p. e00594–22. https://doi.org/10.1128/aac.00594-22 · DOI
  141. Queraltó, 2023, Role and regulation of Clp proteases: a target against gram-positive bacteria, Bacteria, 2, 21, 10.3390/bacteria2010002 · DOI
  142. Ju, Y., et al., Recent advances in Clp protease modulation to address virulence, resistance and persistence of MRSA infection. 2021. 26(9): p. 2190–7. https://doi.org/10.1016/j.drudis.2021.05.014 · DOI
  143. Zheng, J., et al., ClpP participates in stress tolerance, biofilm formation, antimicrobial tolerance, and virulence of Enterococcus faecalis. 2020. 20: p. 1–18. https://doi.org/10.1186/s12866-020-1719-9 · DOI
  144. Wei, B., et al., Anti-infective therapy using species-specific activators of Staphylococcus aureus ClpP. 2022. 13(1): p. 6909. https://doi.org/10.1038/s41467-022-34753-0 · DOI
  145. Xu, L., et al., A clinically selected Staphylococcus aureus clpP mutant survives daptomycin treatment by reducing binding of the antibiotic and adapting a rod-shaped morphology. 2023. 67(6): p. e00328–23. https://doi.org/10.1128/aac.00328-23 · DOI
  146. R.Nassar, Microbial metabolic genes crucial for S. aureus biofilms: an insight from re-analysis of publicly available microarray datasets. 2021. 11: p. 607002. https://doi.org/10.3389/fmicb.2020.607002 · DOI · Paper page
  147. Feng, Y., et al., Effects of ClpP protease on biofilm formation of Enterococcus faecalis. 2021. 29: p. e20200733. https://doi.org/10.1590/1678-7757-2020-0733 · DOI
  148. Liu, 2017, The ATP-dependent protease ClpP inhibits biofilm formation by regulating Agr and cell wall hydrolase Sle1 in Staphylococcus aureus, Front Cell Infect Microbiol, 7, 181, 10.3389/fcimb.2017.00181 · DOI · Paper page
  149. Frees, 2004, Clp ATPases are required for stress tolerance, intracellular replication and biofilm formation in Staphylococcus aureus, Mol Microbiol, 54, 1445, 10.1111/j.1365-2958.2004.04368.x · DOI · Paper page
  150. Karimaei, S., et al., Antibiotic tolerance in biofilm persister cells of Staphylococcus aureus and expression of toxin-antitoxin system genes. 2021. 159: p. 105126. https://doi.org/10.1016/j.micpath.2021.105126 · DOI
  151. Zhao, N., et al., Molybdopterin biosynthesis pathway contributes to the regulation of SaeRS two-component system by ClpP in Staphylococcus aureus. 2022. 13(1): p. 727–39. https://doi.org/10.1080/21505594.2022.2065961 · DOI
  152. Mawla, G.D., et al., ClpP1P2 peptidase activity promotes biofilm formation in Pseudomonas aeruginosa. 2021. 115(6): p. 1094–109. https://doi.org/10.1111/mmi.14649 · DOI
  153. Malishev, R., et al., Inhibition of Staphylococcus aureus biofilm-forming functional amyloid by molecular tweezers. 2021. 28(9): p. 1310–20. e5. https://doi.org/10.1016/j.chembiol.2021.03.013 · DOI
  154. Bhardwaj S, Roy KK. ClpP peptidase as a plausible target for the discovery of novel antibiotics. 2024. 25(2): p. 108–20. https://doi.org/10.2174/0113894501274958231220053714 · DOI
  155. Kim, G.-L., L. Akoolo, D. Parker, The ClpXP protease contributes to Staphylococcus aureus pneumonia. 2020. 222(8): p. 1400–4. https://doi.org/10.1093/infdis/jiaa251 · DOI
  156. Karimaei, S., S.M.K. Aghamir, M.R. Pourmand, Comparative analysis of genes expression involved in type II toxin-antitoxin system in Staphylococcus aureus following persister cell formation. 2024. 51(1): p. 324. https://doi.org/10.1007/s11033-023-09179-6 · DOI
  157. Malik, I.T., et al., Functional characterisation of ClpP mutations conferring resistance to acyldepsipeptide antibiotics in Firmicutes. 2020. 21(14): p. 1997–2012. https://doi.org/10.1002/cbic.201900787 · DOI
  158. Yu, H., et al., Synergistic efficacy of high-intensity ultrasound and chlorine dioxide combination for Staphylococcus aureus biofilm control. 2021. 122: p. 107822.https://doi.org/10.1016/j.foodcont.2020.107822 · DOI
  159. Chen, J., et al., 20S-ginsenoside Rg3 inhibits the biofilm formation and haemolytic activity of Staphylococcus aureus by inhibiting the SaeR/SaeS two-component system. 2022. 71(10): p. 001587. https://doi.org/10.1099/jmm.0.001587 · DOI
  160. Gao, P., et al., SaeR as a novel target for antivirulence therapy against Staphylococcus aureus. 2023. 12(2): p. 2254415. https://doi.org/10.1080/22221751.2023.2254415 · DOI
  161. Zheng, X., et al., Antibacterial and anti-biofilm efficacy of chinese dragon’s blood against Staphylococcus aureus isolated from infected wounds. 2021. 12: p. 672943. https://doi.org/10.3389/fmicb.2021.672943 · DOI
  162. Xiaohua, T., et al., Effect of resveratrol on biofilm formation in Staphylococcus aureus. 2023. 29(14): p. 1950. https://doi.org/10.1016/j.jprot.2021.104357 · DOI
  163. Matsumoto, M., et al., Interaction between Staphylococcus Agr virulence and neutrophils regulates pathogen expansion in the skin. 2021. 29(6): p. 930–40. e4. https://doi.org/10.1016/j.chom.2021.03.007 · DOI
  164. Wang, H., et al., The antiviral drug efavirenz reduces biofilm formation and hemolysis by Staphylococcus aureus. 2021. 70(10): p. 001433. https://doi.org/10.1099/jmm.0.001433 · DOI
  165. Park, I., et al., Antivirulence activities of retinoic acids against Staphylococcus aureus. 2023. 14: p. 1224085. https://doi.org/10.3389/fmicb.2023.1224085 · doi:10.3389/fmicb.2023.1224085
  166. Luo, Z., et al., The role of male hormones in bacterial infections: enhancing Staphylococcus aureus virulence through testosterone-induced Agr activation. 2024. 206(10): p. 401. https://doi.org/10.1007/s00203-024-04130-0 · DOI
  167. Ahator, S.D., et al., Comprehensive virulence profiling and evolutionary analysis of specificity determinants in Staphylococcus aureus two-component systems. 2024. 9(4): p. e00130–24. https://doi.org/10.1128/msystems.00130-24 · DOI
  168. Yang, B., et al., Breaking CHIPS-Mediated immune evasion with tripterin to promote neutrophil chemotaxis against MRSA infection. 2024. 129: p. 111597. https://doi.org/10.1016/j.intimp.2024.111597 · doi:10.1016/j.intimp.2024.111597
  169. Xiao, Y., et al., Phylogenetic analysis and virulence characteristics of methicillin-resistant Staphylococcus aureus ST764-SCC mec II: an emerging hypervirulent clone ST764-t1084 in China. 2023. 12(1): p. 2165969. https://doi.org/10.1080/22221751.2023.2165969 · DOI
  170. Na, M., et al., The expression of von Willebrand factor-binding protein determines joint-invading capacity of Staphylococcus aureus, a Core mechanism of septic arthritis. 2020. 11(6): p. 10.1128/mbio. 02472-20. https://doi.org/10.1128/mBio.02472-20 · doi:10.1128/mbio.02472-20
  171. Zhang, C., et al., Bilobetin attenuates Staphylococcus aureus virulence by targeting Von Willebrand factor-binding protein and staphylocoagulase. 2023. 39(12): p. 358. https://doi.org/10.1007/s11274-023-03812-z · doi:10.1007/s11274-023-03812-z
  172. Nappi F, Avtaar Singh SS. Host–bacterium interaction mechanisms in Staphylococcus aureus endocarditis: a systematic review. 2023. 24(13): p11068. https://doi.org/10.3390/ijms241311068 · DOI
  173. Evans, D.C., et al., GFP fusions of Sec-routed extracellular proteins in Staphylococcus aureus reveal surface-associated coagulase in biofilms. 2023. 10(7): p. 145. https://doi.org/10.15698/mic2023.07.800 · DOI
  174. Shang, Y., et al., Clemastine inhibits the biofilm and hemolytic of Staphylococcus aureus through the GdpP protein. 2022. 10(2): p. e00541–21. https://doi.org/10.1128/spectrum.00541-21 · DOI
  175. Wittekind, M.A., et al., The novel protein ScrA acts through the SaeRS two-component system to regulate virulence gene expression in Staphylococcus aureus. 2022. 117(5): p. 1196–212. https://doi.org/10.1111/mmi.14901 · DOI · Paper page
  176. Awan, F., et al., Genetic diversity in Staphylococcus aureus and its relation to biofilm production. 2021: p. 23. https://doi.org/10.5772/intechopen.99967 · DOI
  177. Butrico CE, Cassat JE. Quorum sensing and toxin production in Staphylococcus aureus osteomyelitis: pathogenesis and paradox. 2020. 12(8): p. 516. https://doi.org/10.3390/toxins12080516 · DOI · Paper page
  178. Cheng, X., et al., Resistance phenotype and genetic features of a heterogeneous Vancomycin intermediate–resistant Staphylococcus aureus strain from an immunocompromised patient. 2024. 55(1): p. 323–32. https://doi.org/10.1007/s42770-023-01192-y · DOI
  179. Cheung, G.Y., J.S. Bae, M. Otto, Pathogenicity and virulence of Staphylococcus aureus. 2021. 12(1): p. 547–69. https://doi.org/10.1080/21505594.2021.1878688 · DOI · Paper page
  180. Loges, L.A., et al., Polyketides from marine-derived Aspergillus welwitschiae inhibit Staphylococcus aureus virulence factors and potentiate vancomycin antibacterial activity in vivo. 2020. 143: p. 104066. https://doi.org/10.1016/j.micpath.2020.104066 · doi:10.1016/j.micpath.2020.104066
  181. Jacob, B., et al., In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus. 2021. 11(1): p. 23425. https://doi.org/10.1038/s41598-021-02709-x · DOI
  182. Yasir, M., D. Dutta, M.D. Willcox, Enhancement of antibiofilm activity of ciprofloxacin against Staphylococcus aureus by administration of antimicrobial peptides. 2021. 10(10): p. 1159. https://doi.org/10.3390/antibiotics10101159 · DOI
  183. Jasim, N.A., et al., ZnO nanoparticles inhibit growth and biofilm formation of vancomycin-resistant S. aureus (VRSA). 2020. 29: p. 101745. https://doi.org/10.1016/j.bcab.2020.101745 · DOI
  184. A.Hashimoto, The combination of silver-containing hydroxyapatite coating and vancomycin has a synergistic antibacterial effect on methicillin-resistant, Staphylococcus aureus biofilm formation. 2020. 9(5): p. 211–8. https://doi.org/10.1302/2046-3758.95.BJR-2019-0326.R1 · doi:10.1302/2046-3758.95.bjr-2019-0326.r1
  185. Zhou, Y., et al., New attempts to inhibit methicillin-resistant Staphylococcus aureus Biofilm? A combination of daptomycin and azithromycin. 2023: p. 7029–40. https://doi.org/10.2147/IDR.S433439 · DOI
  186. Hou, H., et al., The crafty opponent: the defense systems of Staphylococcus aureus and response measures. 2022. 67(2): p. 233–43. https://doi.org/10.1007/s12223-022-00954-9 · DOI
  187. Bai, Z., et al., Multifaceted materials for enhanced osteogenesis and antimicrobial properties on bioplastic polyetheretherketone surfaces: a review. 2024. 9(16): p. 17784–807. https://doi.org/10.1021/acsomega.4c00923 · DOI
  188. Pierezan, 2022, Relevant safety aspects of raw milk for dairy foods processing, 211, 10.1016/bs.afnr.2022.01.001 · DOI
  189. Marcone, G.L., et al., D-amino acids in foods. 2020. 104: p. 555–74. https://doi.org/10.1007/s00253-019-10264-9 · DOI
  190. Warraich, A.A., et al., Evaluation of anti-biofilm activity of acidic amino acids and synergy with ciprofloxacin on Staphylococcus aureus biofilms. 2020. 10(1): p. 9021. https://doi.org/10.1038/s41598-020-66082-x · DOI
  191. Seo, S., et al., Antimicrobial peptides encounter resistance of aureolysin during their action on Staphylococcus aureus biofilm. 2021. 26(2): p. 216–22. https://doi.org/10.1007/s12257-020-0384-z · doi:10.1007/s12257-020-0384-z
  192. Warsi, O.M., et al., Staphylococcus aureus mutants resistant to the feed-additive monensin show increased virulence and altered purine metabolism. 2024. 15(2): p. e03155–23. https://doi.org/10.1128/mbio.03155-23 · DOI
  193. Moghadam, M.J., et al., Inhibitory activity of oliveria decumbens essential oil on Staphylococcus aureus biofilm and planktonic cells. 2022. 9(3): p. 109–14. https://doi.org/10.34172/ajcmi.2022.3397 · doi:10.34172/ajcmi.2022.3397
  194. Monteiro-Neto, V., et al., Cuminaldehyde potentiates the antimicrobial actions of ciprofloxacin against Staphylococcus aureus and Escherichia coli. 2020. 15(5): p. e0232987. https://doi.org/10.1371/journal.pone.0232987 · DOI
  195. da Silva, R.A., I. Afonina, K.A. Kline, Eradicating biofilm infections: an update on current and prospective approaches. 2021. 63: p. 117–25. https://doi.org/10.1016/j.mib.2021.07.001 · DOI
  196. Zurawski DV, McLendon MK. Monoclonal antibodies as an antibacterial approach against bacterial pathogens. 2020. 9(4): p. 155. https://doi.org/10.3390/antibiotics9040155 · DOI · Paper page
  197. Han J, Poma A. Molecular targets for antibody-based anti-biofilm therapy in infective endocarditis. 2022. 14(15): p. 3198. https://doi.org/10.3390/polym14153198 · DOI
  198. Chung PY. Immunotherapies for the prevention and treatment of Staphylococcus aureus infections: updates and challenges. 2023(81): pftad016. https://doi.org/10.1093/femspd/ftad016 · DOI
  199. Mayor, A., et al., Therapeutic antibodies for the treatment of respiratory tract infections—current overview and perspectives. 2021. 9(2): p. 151. https://doi.org/10.3390/vaccines9020151 · DOI
  200. Kharga, K., L. Kumar, S.K.S. Patel, Recent advances in monoclonal antibody-based approaches in the management of bacterial sepsis. 2023. 11(3): p. 765. https://doi.org/10.3390/biomedicines11030765 · DOI · Paper page

200 of 253 shown

Cited by

See all 57

Metadata

Authors
Wang, D., Wang, L., Liu, Q., & Zhao, Y.
Venue
Animals and Zoonoses
Publisher
Elsevier BV
Published
2025-06
Volume
1
Issue
2
Pages
188-202
ISSN
2950-2489
Cited by
57
References
3
Language
en
Licence
Funders
  • Science and Technology Department of Tibet Autonomous Region (CGZH2023000195)
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (RCGHCRB202405)
  • Jilin Scientific and Technological Development Program (20240207010CX)
  • National Natural Science Foundation of China (U22A20340)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Virulence factors in biofilm formation and therapeutic strategies for Staphylococcus aureus: A review. https://app.cochat.ai/papers/10.1016/j.azn.2024.11.003
The paper
Wang, D., Wang, L., Liu, Q., & Zhao, Y. (2025). Virulence factors in biofilm formation and therapeutic strategies for Staphylococcus aureus: A review. Animals and Zoonoses. https://doi.org/10.1016/j.azn.2024.11.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.